Malachite green of Syrian hamster embryo (SHE) cells in primary culture: Transformation is associated with enhanced expression of altered p53, Bcl-2 and decreased sensitivity to apoptosis

Journal of Experimental and Clinical Cancer Research

Volumn 19, Issue 1, 2000, Pages 89-98

  Rao, K V K ^a,b   Mahudawala, D M ^a   Redkar, A A ^b  

^a CANCER RESEARCH INSTITUTE   (India)

^b TATA MEMORIAL HOSPITAL   (India)

Author keywords

Malachite green; Malignant transformation; p53 and bcl 2 overexpression; Resistance to apoptosis; Syrian hamster embryo cells

Indexed keywords

MALACHITE GREEN; PROTEIN BCL 2; PROTEIN P53; COLORING AGENT; FUCHSINE;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; EMBRYO; EMBRYO CULTURE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SYRIAN HAMSTER; ANIMAL; CELL LINE; CELL TRANSFORMATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HAMSTER; HUMAN; PROTO ONCOGENE; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; COLORING AGENTS; CRICETINAE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; GENES, P53; HUMANS; ROSANILINE DYES;

EID: 0034155064     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. WHO, World Health Organisation Technical Report Series No. 309, Geneva. 1965.
2. Windholz M., Budhavani S., Blumetti R.F., Otterbein E.S.:The Merck Index, 10th ed. p.813, Merck & Co. Inc, Rahway, NJ. 1983.
3. Allen J.L., Gofus J.E., Metmertz J.R.: Determination of malachite green residues in the eggs, fry, and adult muscle tissue of rainbow trout (Oncorhynchus my kiss). J. Assoc. Anal. Chem. 77: 553-557, 1994.
4. Panandiker A., Maru G.B., and Rao K.V.K.: Dose response effects of malachite green on free radical formation, lipid peroxidation and DNA damage in Syrian hamster embryo cells and their modulation by antioxidants. Carcinogenesis 15: 2445-2448, 1994.
5. Rao K.V.K.: Comparative cytotoxic effects of the non-permitted food colouring agents metanil yellow, orange II, rhodamine B, and malachite green on hamster dermal and C3H/10T1/2 fibroblasts. Bombay Hospital J 32:61-65,1989.
6. Panandiker A., Fernandes C., Rao K.V.K.: The cytotoxic properties of malachite green are associated with the increased demethylase, arylhydrocarbon hydroxylase and lipid peroxidation in primary cultures of Syrian hamster embryo cells. Cancer Lett 67:93-101,1992.
7. Rao K.V.K.: Inhibition of DNA synthesis in primary rat hepatocyte cultures by malachite green: a new liver tumour promoter. Toxicol. Lett. 81: 107-113, 1995.
8. Fernandes C., Lalitha V.S., Rao K.V.K.: Enhancing effect of malachite green on the development of hepatic pre-neoplastic lesions induced by N-nitrosodiethylamine in rats. Carcinogenesis 12: 839-845, 1991.
9. Rao K.V.K., Fernandes C.L.: Progressive effects of malachite green at varying concentrations on the development of N-nitrosodiethylamine induced hepatic preneoplastic lesions in rats. Tumori 82: 280-286, 1996.
10. Panandiker A., Fernandes C., Gundu Rao T.K., Rao K.V.K.: Morphological transformation of Syrian hamster embryo cells in primary culture by malachite green corelates well with the evidence for formation of reactive free radicals. Cancer Lett 74: 31-36, 1993.
11. Mahudawala D., Redkar A.A., Wagh A.A., Gladstone B., Rao K.V.K.: Malignant transformation of Syrian hamster embryo (SHE) cells in culture by malachite green, an agent of environmental importance. Indian J. Expt. Biol. (Communicated).
12. Klucar J., Al-Rubeai M.: G2 cell cycle arrest and apoptosis are induced in Burkitt's lymphoma cells by the anticancer agent oracin. FEBS Lett. 400: 127-130, 1997.
13. Raff M.C.: Social controls on cell survival and cell death. Nature 356: 397-400, 1992.
14. Steller H.: Mechanisms and genes of cellular suicide. Science 267: 1445-1449, 1995.
15. Goldstein P., Marquet D., Depraetere V.: Homology between reaper and the cell death domains of Fas and TNFR1. Cell 81: 185-186, 1995.
16. Vaux D.L., Haecker G., Strasser A.: An evolutionary perspective on apoptosis. Cell 76: 777-779, 1994.
17. White K., Tahaoglu E., Steller H.: Cell killing by the Drosophila gene reaper. Science 271: 805-807, 1996.
18. Yuan J., Shaham S., Ledaux S., Ellis H.M., Horvitz H.R.: The C.elegans cell death gene Ced-3 encodes a protein similar to mammalian interleukin-1 b-converting enzyme. Cell 75: 641-652, 1993.
19. Soddu S., Sacchi A.: P53 role in DNA repair and tumorigenesis. J. Exp. Clin. Cancer Res. 16: 237-242, 1997.
20. Smith M.L., Fornace, Jr. A.J.: P53 mediated protective responses to UV irradiation. Proc. Natl. Acad. Sci. 94: 12255-12257, 1997.
21. Korsmeyer S.J.: Regulators of cell death. Trends Genet. 11: 101-105, 1995.
22. Reed J.C.: Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124: 1-6, 1994.
23. Reznikoff C.A., Bertram J.S., Brankow D.W., Heidelberger C.: Qualitative and quantitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to post confluence inhibition of cell division. Cancer Res. 33: 3239-3249, 1973.
24. Darzynkiewicz Z., Li X., Gong J.: Assays of cell viability: discrimination of cells dying by apoptosis. Methods in Cell Biology, Vol 41: 15-38, 1994.
25. Zamai L., Falcieri E., Zauli G., Cacaldi A., and Vitale M.: Optimal detection of apoptosis by flow cytometry depends on cell morphology. Cytometry 14: 891-897, 1993.
26. Sgonc R. and Wick G.: Methods for the detection of apoptosis. Int. Arch. Allergy. Immunol. 105: 327-332, 1994.
27. Wyllie A.H.: Glucocorticoid induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555-556, 1980.
28. Kerr J.R.F., Wyllie A.H., Currie A.R.: Apoptosis. A basic biological phenomenon with wide ranging implications in tissue kinetics. Br. J. Cancer 26: 239-257, 1972.
29. Chinnaiyan A.M., Dixit V.M.: The cell-death machine. Curr. Biol. 6: 555-562, 1996.
30. Williams G.T.: Programmed cell death: apoptosis and oncogenesis. Cell 65: 1097-1098, 1991.
31. Fearon E.R., Vogelstein B.: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
32. Stinchcombe S., Buchmann A., Bock K.W., Schwarz M.: Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated tumour promotion in rat liver. Carcinogenesis 16: 1271-1275, 1995.
33. Schulte-Hermann R.: Tumour promotion in the liver Arch.Toxicol. 57: 147-158, 1985.
34. Schulte-Hermann R., Timmermann-Trosiener J., Barthel G., Bursch W.: DNA synthesis, apoptosis and phenotypic expression as determinants of growth by altered foci in rat liver during phenobarbital promotion. Cancer Res. 50: 5127-5135, 1990.
35. Bursch W., Lauer B., Timmermann-Trosiener J., Barthel G., Schuppler J., Schulte-Hermann R.: Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumour promoters. Carcinogenesis 5: 453-458, 1984.
36. Bursch W., Oberhammer F., Schulte-Hermann R.: Cell death by apoptosis and its protective role against disease. Trends. Pharm. Sci. 13: 245-251, 1992.
37. Yin X.M., Oltvai Z.N., Veis-Novack D.J., Linette G.P., Korsmeyer S.J.: Bcl-2 gene family and the regulation of programmed cell death. Cold Spring Harbor Symp. Quant. Biol. 59: 387-393, 1994.
38. Hockenbery D.M., Zutler M., Hickey W., Nahin M., Korsmeyer S.J. : BCL-2 protein is topographically restricted in tissues characterised by apoptotic cell death. Proc Natl Acad Sci. U.S.A. 88: 6961-6965, 1991.
39. Zhao M., Zhang N.X., Economou M., Blaha I., Laissue J.A., Zimmermann A. : Immunohistochemical detection of bcl-2 protein in liver lesions: bcl-2 protein is expressed in hepatocellular carcinomas but not in liver cell dysplasia. Histopatholosy 25: 237-245, 1994.
40. Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., Korsmeyer S.J.: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75: 241-251, 1993.
41. Kane D.J., Sarafian T.A., Anton R., Hahn H., Gralla E.B., Valentine J.S., Ord T., Bredesent D.E.: Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262: 1274-1277, 1993.
42. Hockenbery D., Nunez G., Milliman C., Schreiber R.D., Korsmeyer S.J.: Bcl-2 is an inner mitochondria membrane protein that blocks programmed cell death. Nature 348: 334-336, 1990.
43. Lo Coco F., Gaidano G., Louie D.C., Offit K., Chaganti R.S.K., Dalla-Favara R.: P53 mutations are associated with histologic transformation of follicular lymphoma. Blood 82: 2289-2295, 1993.
44. Koneko Y., Tsukamoto A.: Apoptosis and nuclear levels of p53 protein and proliferating cell nuclear antigen in human hepatoma cells cultured with tumor promoters. Cancer Lett 91:11-17, 1995.
45. Soussi T., Lgros Y., Lubin R., Ory K, Schlichtholz B. : Multifactorial analysis of p53 alterations in Human Cancer: A review. Int J Cancer 57:1-9, 1994.
46. Hollstein M., Sidransky D., Vogelstein B., Harris C.C.: P53 mutations in human cancers. Science 253: 49-53, 1991.
47. Levine A., Momand J., Finlay C.A.: The p53 tumor suppressor gene. Nature 351: 453-456, 1991.
48. Vogelstein B., Kinzler K.W.: P53 function and dysfunction. Cell 70: 523-526, 1992.
49. Lane D.P.: P53 guardian of genome. Nature 358: 15-16, 1992.
50. Zambetti G.P., Levine A.J.: A comparison of the biological activities of wild-type and mutant p53. FASEB J. 7: 855-865, 1993.
51. Sander C.A., Yano T., Clark H.M., Harris C., Longo D.L., Jaffe E.S., Roffeld M.: P53 mutations is associated with progression in follicular lymphoma. Blood 82: 1994-2004, 1993.
52. Miyashita T., Reed J.C.: Bcl-2 gene transfer increases relative resistance of S49.1 and WEH 17-2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res. 52: 5417-5411, 1992.
53. Lowe S.W., Ruley H.E., Jacks T., Housman D.E.: P53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967, 1993.